Currently out of the existing stock ratings of Kevin Caliendo, 147 are a BUY (49.66%), 11 are a SELL (3.72%), 138 are a HOLD (46.62%).

Kevin Caliendo

Work Performance Price Targets & Ratings Chart

Analyst Kevin Caliendo, currently employed at UBS, carries an average stock price target met ratio of 62.63% that have a potential upside of 18.39% achieved within 238 days.

Kevin Caliendo’s has documented 576 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GDRX, Goodrx Holdings at 13-May-2025.

Wall Street Analyst Kevin Caliendo

Analyst best performing recommendations are on AGTI (AGILITI).
The best stock recommendation documented was for AGTI (AGILITI) at 5/18/2021. The price target of $16 was fulfilled within 2 days with a profit of $0.81 (5.33%) receiving and performance score of 26.66.

Average potential price target upside

of $65.54 (29.19%) on CI (CIGNA CORP).
of $55.63 (17.45%) on ALGN (ALIGN TECHNOLOGY).
of $50.7 (15.92%) on MCK (MCKESSON).

ABC AmerisourceBergen ALGN Align Technology CAH Cardinal Health CERN Cerner Corp CI Cigna Corp CVS CVS Health Corp DGX Quest Diagnostics HSIC Henry Schein LH Laboratory of America Holdings MCK McKesson OMI Owens & Minor SDC SmileDirectClub TDOC Teladoc TEVA Teva Pharma Industries Ltd ADR UNH UnitedHealth Group WBA Walgreens Boots Alliance ALHC Alignment Healthcare LLC JNJ Johnson & Johnson LFST Lifestance Health Group SGFY Signify Health DPLO Diplomat Pharmacy XRAY Dentsply Sirona ELV Elevance Health HUM Humana PINC Premier AGTI Agiliti AHCO Adapthealth Corp AMWL American Well Corp PDCO Patterson Companies MOH Molina Healthcare CNC Centene Corp EVH Evolent Health GDRX Goodrx Holdings

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Charles Rhyee (LAKE STREET)